Literature DB >> 20736235

Determination of antibiotic dosage adjustments in patients with renal impairment: elements for success.

Nimish Patel1, Marc H Scheetz, George L Drusano, Thomas P Lodise.   

Abstract

This report reviews a contemporary methodology for determining antibiotic dosage modifications among patients with renal impairment. Historically, the approach to identifying renal dosage adjustments has focused on achieving comparable concentration-time profiles between patients with renal impairment and those with normal kidney function. While this approach is intuitive, it fails to incorporate the relationship between antibiotic exposure and effect in the renal dose selection process. A candidate renal dosing scheme that is worthy of incorporation into clinical practice should balance the probability of achieving the exposure target associated with success against the risks of toxicity and the emergence of resistance. This review describes a methodology for optimally identifying dosage adjustments in patients with impaired renal function using extended-infusion piperacillin/tazobactam as an illustrative example.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20736235     DOI: 10.1093/jac/dkq323

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  7 in total

1.  Audit of renal drug dosing: comparison of 2 methods and evaluation of pharmacists' knowledge, attitudes, and behaviour.

Authors:  Kimberley L Caouette; Colette B Raymond; Lindsay D Meyer; Nicholas Honcharik
Journal:  Can J Hosp Pharm       Date:  2012-07

2.  A Robust Statistical Approach to Analyse Population Pharmacokinetic Data in Critically Ill Patients Receiving Renal Replacement Therapy.

Authors:  Sanjoy Ketan Paul; Jason A Roberts; Jeffrey Lipman; Renae Deans; Mayukh Samanta
Journal:  Clin Pharmacokinet       Date:  2019-02       Impact factor: 6.447

Review 3.  Translational PK/PD of anti-infective therapeutics.

Authors:  Chetan Rathi; Richard E Lee; Bernd Meibohm
Journal:  Drug Discov Today Technol       Date:  2016-10-28

4.  Telavancin pharmacokinetics and pharmacodynamics in patients with complicated skin and skin structure infections and various degrees of renal function.

Authors:  T P Lodise; J M Butterfield; S S Hegde; E Samara; S L Barriere
Journal:  Antimicrob Agents Chemother       Date:  2012-01-17       Impact factor: 5.191

Review 5.  Pharmacokinetic and Pharmacodynamic Principles of Anti-infective Dosing.

Authors:  Nikolas J Onufrak; Alan Forrest; Daniel Gonzalez
Journal:  Clin Ther       Date:  2016-07-20       Impact factor: 3.393

Review 6.  Considerations for Dose Selection and Clinical Pharmacokinetics/Pharmacodynamics for the Development of Antibacterial Agents.

Authors:  M L Rizk; S M Bhavnani; G Drusano; A Dane; A E Eakin; T Guina; S H Jang; J F Tomayko; J Wang; L Zhuang; T P Lodise
Journal:  Antimicrob Agents Chemother       Date:  2019-04-25       Impact factor: 5.191

7.  Piperacillin concentration in relation to therapeutic range in critically ill patients--a prospective observational study.

Authors:  Johannes Zander; Gundula Döbbeler; Dorothea Nagel; Barbara Maier; Christina Scharf; Mikayil Huseyn-Zada; Jette Jung; Lorenz Frey; Michael Vogeser; Michael Zoller
Journal:  Crit Care       Date:  2016-04-04       Impact factor: 9.097

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.